|Bid||24.50 x 1100|
|Ask||24.67 x 1000|
|Day's Range||24.36 - 26.19|
|52 Week Range||22.88 - 45.68|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Sep 5, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||43.56|
Shares of Livongo Health Inc. rose 1% in premarket trading Thursday, after the digital health company reported its first quarterly results since going public, with a wider-than-expected loss but revenue that rose above forecasts. The net loss widened to $14.3 million, or 76 cents a share, from $6.2 million, or 38 cents a share, in the year-ago period. Excluding non-recurring items, the adjusted loss per share was 46 cents, compared with the FactSet per-share loss consensus of 15 cents. Revenue rose 156% to $40.9 million, above the FactSet consensus of $39.7 million. Enrollment for Diabetes Members grew 140% to 192,934, while clients increased 92% to 720. For the third quarter, Livongo expects revenue of $42 million to $43 million, surrounding the FactSet consensus of $42.3 million. The stock has lost 19% since it closed at $38.10 on its first day of trading on July 25, while the S&P 500 has declined 2.2% over the same time.
Shares of healthcare industry solutions provider Livongo Health were rising in premarket trading Thursday after the company reported a second-quarter loss narrower than analysts' expectations. The Mountain View, California-based company reported a 156% increase in year-over-year revenue to $40.
Shares of Livongo Health Inc (NASDAQ: LVGO ) have lost nearly 20% since its late July IPO , and investors should take advantage of the discount valuation, according to Morgan Stanley. The Analyst Ricky ...
MOUNTAIN VIEW, Calif., Aug. 27, 2019 -- Livongo Health, Inc. (Nasdaq: LVGO), a leading Applied Health Signals company empowering people with chronic conditions to live better.
Today, Livongo announced that Founder and Executive Chairman Glen Tullman will be honored with a Robert F. Kennedy Human Rights Ripple of Hope Award for his career focused on improving the safety, empathy, and efficiency of our healthcare system. The Ripple of Hope Award celebrates leaders of the international business, entertainment, and activist communities who have demonstrated a commitment to social change. Past honorees include President Barack Obama, Archbishop Desmond Tutu, Bono, George Clooney, and Robert F. Smith.
Livongo Health Inc (NASDAQ: LVGO) shares have bumped up more than 30% since the company went public at the end of July, raising interest in the digital health platform company. KeyBanc Capital Market's Donald Hooker initiated coverage of Livongo Health with an Overweight rating and $46 price target. Livongo uses technology to manage chronic disease treatment, mostly in patients with diabetes, and both analysts said the company’s business model appear to give it a long growth runway.
MOUNTAIN VIEW, Calif., Aug. 07, 2019 -- Livongo Health, Inc. (Nasdaq: LVGO) today announced it will hold a conference call on Thursday, September 5, 2019 at 8:00 a.m. Eastern.
MOUNTAIN VIEW, Calif., July 29, 2019 -- Livongo Health, Inc., (Nasdaq: LVGO) today announced the closing of its initial public offering of 14,590,050 shares of its common stock.
MOUNTAIN VIEW, Calif., July 24, 2019 -- Livongo Health, Inc. (Livongo) today announced the pricing of its initial public offering of 12,687,000 shares of its common stock at a.
The company's shares have been approved for listing on the Nasdaq under the ticker symbol LVGO. Kinnevik Online AB, which holds more than 5% of Livongo's outstanding capital stock, has expressed willingness to buy up to $20 million worth of shares or about 800,000 shares, the company said in the filing. Morgan Stanley, Goldman Sachs and JPMorgan are the lead underwriters for the offering.
For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud . The IPO dates below are expected but not confirmed. Castle Biosciences Inc (NASDAQ: CSTL ) will issue more than 3.33 million ...
Fortune's Sy Mukherjee interviews Livongo CEO Zane Burke and President Jennifer Schneider at NASDAQ Marketsite in Manhattan, NY.